Targeting the kappa opioid receptor for analgesia and antitumour effects.

0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: David G Lambert, Joshua S Mincer

Ngôn ngữ: eng

Ký hiệu phân loại:

Thông tin xuất bản: England : British journal of anaesthesia , 2025

Mô tả vật lý:

Bộ sưu tập: NCBI

ID: 217039

Thêm vào giỏ Liên kết toàn văn

Kappa opioid (KOP) receptor agonists have analgesic actions in a range of models, but central side-effects can limit their utility. In addition, non-analgesic actions of opioid receptors are receiving significant research interest. A recent article reports that high KOP receptor expression in glioma tissue correlates with improved survival and that KOP receptor agonism further promotes apoptosis of glioma cells through regulation of the p38 MAPK oncogenic pathway. This suggests that KOP receptor ligands could be developed as chemotherapeutic adjuncts in addition to their use as analgesics.

Tạo bộ sưu tập với mã QR